Evidence map›Paper›PMID 40542140›Full record

ArticleSurgical endoscopy2025

International validation of the distal pancreatectomy fistula risk score: evaluation in minimally invasive and open surgery.

Philip C Müller, Suna Erdem, Christoph Kuemmerli, Felix Nickel, O H Fiete Gehrisch, Faik G Uzunoglu, Amelie Hannoschöck, Noa L E Aegerter, Caroline Berchtold, Jan Philipp Jonas and 24 more

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Philip C MüllerDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. philip.mueller@clarunis.ch.ORCID http://orcid.org/0000-0001-8317-3449
Suna ErdemDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Christoph KuemmerliDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Felix NickelDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
O H Fiete GehrischDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Faik G UzunogluDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Amelie HannoschöckDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Noa L E AegerterDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Caroline BerchtoldDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Jan Philipp JonasDepartment of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
Michael C FreyDepartment of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
Beat MoeckliDepartment of Surgery, University Hospitals of Geneva, Geneva, Switzerland.
Christian TosoDepartment of Surgery, University Hospitals of Geneva, Geneva, Switzerland.
Julia MühlhäusserDepartment of General Surgery, Cantonal Hospital of Lucerne, Lucerne, Switzerland.
Jörn-Markus GassDepartment of General Surgery, Cantonal Hospital of Lucerne, Lucerne, Switzerland.
Riccardo PellegriniHepato Pancreato Biliary (HPB) and Liver Transplant Surgery, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
Umberto CilloHepato Pancreato Biliary (HPB) and Liver Transplant Surgery, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
Giovanni MarchegianiHepato Pancreato Biliary (HPB) and Liver Transplant Surgery, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
Cristiano GuidettiHepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy.
Fabrizio Di BenedettoHepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy.
Anna S WenningDepartment of Visceral Surgery and Medicine, Insel, Bern University Hospital, University of Bern, Bern, Switzerland.
Beat GloorDepartment of Visceral Surgery and Medicine, Insel, Bern University Hospital, University of Bern, Bern, Switzerland.
Kim C WagnerDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Asklepios Hospital Barmbek, Hamburg, Germany.
Karl J OldhaferDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Asklepios Hospital Barmbek, Hamburg, Germany.
Christoph TschuorDepartment of Digestive Diseases, Transplantation and General Surgery Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Paul Suno KrohnDepartment of Digestive Diseases, Transplantation and General Surgery Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Stefan K BurgdorfDepartment of Digestive Diseases, Transplantation and General Surgery Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Alberto García-PicazoHepato-Biliary and Pancreatic Surgery Unit, Department of Surgery, Hospital del Mar, Pompeu Fabra University, Barcelona, Spain.
Patricia Sánchez-VelázquezHepato-Biliary and Pancreatic Surgery Unit, Department of Surgery, Hospital del Mar, Pompeu Fabra University, Barcelona, Spain.
Didier RoulinDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, USA.
John B MartinieDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, USA.
Thilo HackertDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Beat P MüllerDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Adrian T BilleterDepartment of Surgery, Clarunis University Digestive Health Care Center, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostoperative pancreatic fistula (POPF) remains the most severe complication following distal pancreatectomy (DP). The preoperative distal fistula risk score (D-FRS) was introduced to predict the POPF risk. The aim of this study was to externally validate the D-FRS in an international expert center cohort.

methodsThis international, multicenter, retrospective cohort study included open and minimally invasive DP for benign and malignant lesions performed from 01/2014 until 12/2023 in 12 centres from 6 countries, that each performed more than 50 pancreatectomies annually. The D-FRS was calculated from pancreatic thickness and duct size. Predicted and actual POPF were compared using sensitivity, specificity and area under the curve (AUC).

resultsA total of 778 patients underwent DP of whom 284 (39%) underwent robotic, 278 (38%) open and 165 (23%) laparoscopic DP. The rate of POPF was 32%. The sensitivity, specificity and AUC of the D-FRS for the overall cohort was 32%, 63% and 48% (95% CI 44-51%), respectively. The AUC for open, laparoscopic and robotic DP was 54% (48-60%), 47% (39-55%) and 45% (39-50%), respectively. For neoadjuvant therapy naïve patients the AUC was 52.3%. On multivariate analysis POPF was associated with body mass index (odds ratio 1.04 (95% CI 1.01-1.07)), protective factors were neoadjuvant therapy (OR 0.54 (0.22-0.94)) and the robotic approach (OR 0.64 (0.42-0.97)).

conclusionsThe preoperative D-FRS showed insufficient discrimination to identify patients who develop POPF after DP irrespective of the surgical approach. Novel preoperative POPF risk scores are needed, considering the standard minimally invasive approach and the widespread use of neoadjuvant therapy.

Indexed as

LaparoscopyPancreatectomyPancreatic FistulaPostoperative ComplicationsRobotic Surgical ProceduresAdultAgedFemaleHumansMaleMiddle AgedMinimally Invasive Surgical ProceduresRetrospective StudiesRisk AssessmentSensitivity and SpecificityComplicationsDistal pancreatectomyOutcome researchPancreatic surgeryRobotic surgery

Identifiers

PMID40542140
PMCPMC12287223

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.